Upgrades

Coromandel International (CRIN) continued to deliver healthy operating performance in 2QFY26 (EBIT up 15% YoY), supported by continued traction in crop protection (EBIT up 34% YoY) and nutrients and allied (EBIT up 16% YoY).

The company aims to enhance capacity utilization through backward integration, with the launch of new products is expected to strengthen its near-term revenue outlook. New segments such as drones and retail, along with stabilized raw material prices and operational improvements, are likely to support profitability going forward. Accordingly, we revise our rating on the stock to ACCUMULATE, with a revised...

Q4FY2025 Consolidated revenue of Rs. 4,988 crore (up 27.5%y-o-y) was ahead of our estimates. Revenues increased due to strong volume growth in the fertilizer and the crop protection business.

Coromandel International (CRIN) reported a robust operating performance in 4QFY25 (EBIT up 62% YoY), aided by strong growth in both the Crop Protection business (EBIT up 60% YoY) and the Nutrients and Allied business (Adj. EBIT up 38% YoY; includes INR509.4m toward an adjustment for the write-down of
certain assets across plants).

Coromandel International announced the signing of definitive agreements to acquire a majority stake in NACL Industries Limited (NACL). Coromandel is set to acquire 53% shareholding in NACL industries, for consideration of Rs 820 Crores at Rs 76.7/- price per share from the current promoter KLR Products Limited.

Coromandel International (CRIN) reported subdued operating performance in 2QFY25 (EBIT down 10% YoY) due to a lower NBS rate and high raw material prices.

Revenues reached Rs. 7,433 crore, rising by 6% y-o-y and by 57% q-o-q, primarily driven by higher volumes of primary sales.

In this note we have analyzed the volume performance for CRIN in 3QFY22, the trend in its key RMs, Rabi sowing in its key markets, and capacity expansion in sulfuric acid. The key insights are highlighted below:...